Early research (Phase 1)Study completedNCT02696642What this trial is testingPhase I Study of Anetumab Ravtansine in Hepatic or Renal ImpairmentWho this might be right forNeoplasms Bayer 54
Early research (Phase 1)Study completedNCT02824042What this trial is testingThorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and ItraconazoleWho this might be right forMedical Oncology Bayer 63
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Very early researchUnknownNCT04489862What this trial is testingΑPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid TumorsWho this might be right forNon-small-cell Lung CancerMesothelioma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Not applicableLooking for participantsNCT06717022What this trial is testingA Clinical Study of CHT102 in Mesothelin Positive Advanced Solid TumorsWho this might be right forMesothelin Positive Tumors Tianjin Medical University Cancer Institute and Hospital 24
Early research (Phase 1)UnknownNCT05089266What this trial is testingStudy of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid TumorsWho this might be right forColorectal Cancer Shanghai Cell Therapy Group Co.,Ltd 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451849What this trial is testingA Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerWho this might be right forMesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more TCR2 Therapeutics 6
Early research (Phase 1)Study completedNCT00325494What this trial is testingMORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerWho this might be right forPancreatic CancerMesotheliomaOvarian Cancer+1 more Morphotek 24
Early research (Phase 1)Ended earlyNCT02317419What this trial is testingRO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid TumorsWho this might be right forCancer Hoffmann-La Roche 15
Testing effectiveness (Phase 2)UnknownNCT05944185What this trial is testingPhase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Shanghai Cell Therapy Group Co.,Ltd 42
Early research (Phase 1)Study completedNCT03102320What this trial is testingPhase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid TumorsWho this might be right forNeoplasms Bayer 173
Early research (Phase 1)Looking for participantsNCT05568680What this trial is testingSynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or MesotheliomaWho this might be right forOvarian CancerCholangiocarcinoma RecurrentMesothelioma, Malignant Verismo Therapeutics 42
Early research (Phase 1)Looking for participantsNCT06760364What this trial is testingA Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic CancerWho this might be right forAdvanced Pancreatic Cancers Tianjin Medical University Cancer Institute and Hospital 21
Testing effectiveness (Phase 2)UnknownNCT03615313What this trial is testingPD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid TumorWho this might be right forAdvanced Solid Tumor Shanghai Cell Therapy Research Institute 50
Early research (Phase 1)UnknownNCT02580747What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoWho this might be right forMalignant MesotheliomaPancreatic CancerOvarian Tumor+3 more Chinese PLA General Hospital 20
Not applicableLooking for participantsNCT07010523What this trial is testingAnti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsWho this might be right forMesothelin-positive Advanced Malignant Solid Tumors Zhejiang University 24
Early research (Phase 1)Not Yet RecruitingNCT05783089What this trial is testingMSLN-targeted CAR-T Cells in Solid Tumors.Who this might be right forMesothelin-positive Advanced Malignant Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 87
Early research (Phase 1)UnknownNCT06256055What this trial is testingPhase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsWho this might be right forMalignant MesotheliomaColorectal CancerBile Duct Cancer+4 more UTC Therapeutics Inc. 24
Early research (Phase 1)Study completedNCT04034238What this trial is testingMesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid TumorsWho this might be right forNeoplasms With Mesothelin ExpressionEpithelioid MesotheliomaCholangiocarcinoma, Extrahepatic+1 more National Cancer Institute (NCI) 19
Early research (Phase 1)Active Not RecruitingNCT02792114What this trial is testingT-Cell Therapy for Advanced Breast CancerWho this might be right forBreast CancerMetastatic HER2-negative Breast Memorial Sloan Kettering Cancer Center 186